Jan 12, 2021 / 07:00PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst for JPMorgan. And we're continuing the 2021 Healthcare Conference today with Amarin. I'm joined by the company's CEO, John Thero.
Before I turn it over to him, I just want to let you know that instead of going across the hall to the breakout room this year, you can ask questions via the portal by clicking that blue Ask a Question button on the webcast, that will send me the questions. I can ask them to management once we move to Q&A after the presentation.
So with that out of the way, let me turn it over to John.
John F. Thero - Amarin Corporation plc - President, CEO & Director
Thanks, Jess, for the invitation and introduction. And thanks to everybody else for joining us here today. I'm excited to be talking about Amarin and what is an upcoming year that we're very encouraged by.
Before I get into reasons for encouragement, I'll start on Slide 2, where I will be making
Amarin Corporation PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers